Editorial: Methods in genitourinary oncology

por Jang, Albert, Sella, Avishay, Nassar, Amin H., Koshkin, Vadim S.
Publicado 2023

Hepatic Failure Due to Cholestatic Hepatitis C in an Immunosuppressed Patient Treated With Elbasvir and Grazeprevir

por Nassar, Amin H., Abdul-Jawad, Baraa M., Barnes, David S.
Publicado 2018

MITF is a driver oncogene and potential therapeutic target in kidney angiomyolipoma tumors through transcriptional regulation of CYR61

por Zarei, Mahsa, Giannikou, Krinio, Du, Heng, Liu, Heng-Jia, Duarte, Melissa, Johnson, Sneha, Nassar, Amin H., Widlund, Hans R., Henske, Elizabeth P., Long, Henry W., Kwiatkowski, David J.
Publicado 2020

Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion

por Zarei, Mahsa, Du, Heng, Nassar, Amin H., Yan, Rachel E., Giannikou, Krinio, Johnson, Sneha H., Lam, Hilaire C., Henske, Elizabeth P., Wang, Yubao, Zhang, Tinghu, Asara, John, Kwiatkowski, David J.
Publicado 2019

Variation in targetable genomic alterations in non-small cell lung cancer by genetic ancestry, sex, smoking history, and histology

por Adib, Elio, Nassar, Amin H., Abou Alaiwi, Sarah, Groha, Stefan, Akl, Elie W., Sholl, Lynette M., Michael, Kesi S., Awad, Mark M., Jӓnne, Pasi A., Gusev, Alexander, Kwiatkowski, David J.
Publicado 2022

Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors

por Nuzzo, Pier Vitale, Pond, Gregory R, Abou Alaiwi, Sarah, Nassar, Amin H, Flippot, Ronan, Curran, Catherine, Kilbridge, Kerry L, Wei, Xiao X, McGregor, Bradley A, Choueiri, Toni, Harshman, Lauren C, Sonpavde, Guru
Publicado 2020

FGFR2/3 genomic alterations and response to Enfortumab Vedotin in metastatic urothelial carcinoma

por Adib, Elio, El‐Zarif, Talal, Jain, Rohit K., Skelton, William P., Freeman, Dory, Curran, Catherine, Akl, Elie W., Nassar, Amin H., Ravi, Praful, Mantia, Charlene, Kwiatkowski, David J., Choueiri, Toni K., Sonpavde, Guru P.
Publicado 2021

CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer

por Adib, Elio, El Zarif, Talal, Nassar, Amin H., Akl, Elie W., Abou Alaiwi, Sarah, Mouhieddine, Tarek H., Esplin, Edward D., Hatchell, Kathryn, Nielsen, Sarah M., Rana, Huma Q., Choueiri, Toni K., Kwiatkowski, David J., Sonpavde, Guru
Publicado 2021

Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia

por Tahri, Sabrin, Mouhieddine, Tarek H., Redd, Robert, Lampe, Luisa, Nilsson, Katarina I., El-Khoury, Habib, Su, Nang Kham, Nassar, Amin H., Adib, Elio, Bindra, Govind, Abou Alaiwi, Sarah, Trippa, Lorenzo, Steensma, David P., Castillo, Jorge J., Treon, Steven P., Ghobrial, Irene M., Sperling, Adam S.
Publicado 2022

Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma

por Abou Alaiwi, Sarah, Xie, Wanling, Nassar, Amin H, Dudani, Shaan, Martini, Dylan, Bakouny, Ziad, Steinharter, John A, Nuzzo, Pier Vitale, Flippot, Ronan, Martinez-Chanza, Nieves, Wei, Xiao, McGregor, Bradley A, Kaymakcalan, Marina D, Heng, Daniel Y C, Bilen, Mehmet A, Choueiri, Toni K, Harshman, Lauren C
Publicado 2020

Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study

por Martinez Chanza, Nieves, Xie, Wanling, Issa, Majd, Dzimitrowicz, Hannah, Tripathi, Abhishek, Beuselinck, Benoit, Lam, Elaine, Zakharia, Yousef, Mckay, Rana, Shah, Sumit, Mortazavi, Amir, R. Harrison, Michael, Sideris, Spyridon, Kaymakcalan, Marina D, Abou Alaiwi, Sarah, Nassar, Amin H, Nuzzo, Pier Vitale, Hamid, Anis, K Choueiri, Toni, C Harshman, Lauren
Publicado 2020

Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma

por Nassar, Amin H., Abou Alaiwi, Sarah, AlDubayan, Saud H., Moore, Nicholas, Mouw, Kent W., Kwiatkowski, David J., Choueiri, Toni K., Curran, Catherine, Berchuck, Jacob E., Harshman, Lauren C., Nuzzo, Pier V., Chanza, Nieves Martinez, Van Allen, Eliezer, Esplin, Edward D., Yang, Shan, Callis, Thomas, Garber, Judy E., Rana, Huma Q., Sonpavde, Guru
Publicado 2019

A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma

por Nassar, Amin H., Mouw, Kent W., Jegede, Opeyemi, Shinagare, Atul B., Kim, Jaegil, Liu, Chia-Jen, Pomerantz, Mark, Harshman, Lauren C., Van Allen, Eliezer M., Wei, Xiao X., McGregor, Bradley, Choudhury, Atish D., Preston, Mark A., Dong, Fei, Signoretti, Sabina, Lindeman, Neal I., Bellmunt, Joaquim, Choueiri, Toni K., Sonpavde, Guru, Kwiatkowski, David J.
Publicado 2019

Epigenomic profiling nominates master transcription factors (TFs) driving sarcomatoid differentiation (SD) of renal cell carcinoma (RCC)

por El Zarif, Talal, Semaan, Karl, Eid, Marc, Fortunato, Brad, Nassar, Amin H, Abou Alaiwi, Sarah, Bakouny, Ziad, Shah, Valisha, Maria Saliby, Renee, Seo, Ji-Heui, Labaki, Chris, Saad, Eddy, Garinet, Simon, Matar, Sayed, Ahmar, Nourhan, Nabil Laimon, Yasmin, Mary Lee, Gwo-Shu, Pomerantz, Mark, E Berchuck, Jacob, Viswanathan, Srinivas R, Signoretti, Sabina, Van Allen, Eliezer M, Braun, David, K Choueiri, Toni, L Freedman, Matt, Baca, Sylvan S
Publicado 2023

Epigenomic charting and functional annotation of risk loci in renal cell carcinoma

por Nassar, Amin H., Abou Alaiwi, Sarah, Baca, Sylvan C., Adib, Elio, Corona, Rosario I., Seo, Ji-Heui, Fonseca, Marcos A. S., Spisak, Sandor, El Zarif, Talal, Tisza, Viktoria, Braun, David A., Du, Heng, He, Monica, Flaifel, Abdallah, Alchoueiry, Michel, Denize, Thomas, Matar, Sayed G., Acosta, Andres, Shukla, Sachet, Hou, Yue, Steinharter, John, Bouchard, Gabrielle, Berchuck, Jacob E., O’Connor, Edward, Bell, Connor, Nuzzo, Pier Vitale, Mary Lee, Gwo-Shu, Signoretti, Sabina, Hirsch, Michelle S., Pomerantz, Mark, Henske, Elizabeth, Gusev, Alexander, Lawrenson, Kate, Choueiri, Toni K., Kwiatkowski, David J., Freedman, Matthew L.
Publicado 2023

Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant

por Mouhieddine, Tarek H., Sperling, Adam S., Redd, Robert, Park, Jihye, Leventhal, Matthew, Gibson, Christopher J., Manier, Salomon, Nassar, Amin H., Capelletti, Marzia, Huynh, Daisy, Bustoros, Mark, Sklavenitis-Pistofidis, Romanos, Tahri, Sabrin, Hornburg, Kalvis, Dumke, Henry, Itani, Muhieddine M., Boehner, Cody J., Liu, Chia-Jen, AlDubayan, Saud H., Reardon, Brendan, Van Allen, Eliezer M., Keats, Jonathan J., Stewart, Chip, Mehr, Shaadi, Auclair, Daniel, Schlossman, Robert L., Munshi, Nikhil C., Anderson, Kenneth C., Steensma, David P., Laubach, Jacob P., Richardson, Paul G., Ritz, Jerome, Ebert, Benjamin L., Soiffer, Robert J., Trippa, Lorenzo, Getz, Gad, Neuberg, Donna S., Ghobrial, Irene M.
Publicado 2020

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma

por Bakouny, Ziad, Braun, David A., Shukla, Sachet A., Pan, Wenting, Gao, Xin, Hou, Yue, Flaifel, Abdallah, Tang, Stephen, Bosma-Moody, Alice, He, Meng Xiao, Vokes, Natalie, Nyman, Jackson, Xie, Wanling, Nassar, Amin H., Abou Alaiwi, Sarah, Flippot, Ronan, Bouchard, Gabrielle, Steinharter, John A., Nuzzo, Pier Vitale, Ficial, Miriam, Sant’Angelo, Miriam, Forman, Juliet, Berchuck, Jacob E., Dudani, Shaan, Bi, Kevin, Park, Jihye, Camp, Sabrina, Sticco-Ivins, Maura, Hirsch, Laure, Baca, Sylvan C., Wind-Rotolo, Megan, Ross-Macdonald, Petra, Sun, Maxine, Lee, Gwo-Shu Mary, Chang, Steven L., Wei, Xiao X., McGregor, Bradley A., Harshman, Lauren C., Genovese, Giannicola, Ellis, Leigh, Pomerantz, Mark, Hirsch, Michelle S., Freedman, Matthew L., Atkins, Michael B., Wu, Catherine J., Ho, Thai H., Linehan, W. Marston, McDermott, David F., Heng, Daniel Y. C., Viswanathan, Srinivas R., Signoretti, Sabina, Van Allen, Eliezer M., Choueiri, Toni K.
Publicado 2021